IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA
IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA
Read moreTue, 30th Mar 2021 07:53
IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA
Read more(Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake.
Read moreUK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale
Read moreIP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress
Read more(Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen.
Read moreIP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test
Read more(Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche.
Read moreTOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy
Read moreLONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers
Read moreLONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises
Read moreUK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform
Read moreUK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup
Read moreIP Group Net Asset Value Declines Amid Record Cash Realisations
Read more(Sharecast News) - IP Group reported net portfolio gains of £34.9m, or 3%, in its first half on Wednesday, with cash realisations rising to £113.7m from £7.1m a year earlier, exceeding investment by £76.9m.
Read moreLONDON MARKET CLOSE: Manufacturing PMIs Spark Strong Start To August
Read more